522 related articles for article (PubMed ID: 27540018)
21. Pulmonary phenotypes associated with genetic variation in telomere-related genes.
Hoffman TW; van Moorsel CHM; Borie R; Crestani B
Curr Opin Pulm Med; 2018 May; 24(3):269-280. PubMed ID: 29474209
[TBL] [Abstract][Full Text] [Related]
22. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
[TBL] [Abstract][Full Text] [Related]
23. Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Yilmaz C; Brewington C; Wang R; Xing C; Hsia CCW; Garcia CK
Chest; 2011 Sep; 140(3):753-763. PubMed ID: 21349926
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic pulmonary fibrosis: update on genetic discoveries.
Garcia CK
Proc Am Thorac Soc; 2011 May; 8(2):158-62. PubMed ID: 21543794
[TBL] [Abstract][Full Text] [Related]
25. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis.
Petrovski S; Todd JL; Durheim MT; Wang Q; Chien JW; Kelly FL; Frankel C; Mebane CM; Ren Z; Bridgers J; Urban TJ; Malone CD; Finlen Copeland A; Brinkley C; Allen AS; O'Riordan T; McHutchison JG; Palmer SM; Goldstein DB
Am J Respir Crit Care Med; 2017 Jul; 196(1):82-93. PubMed ID: 28099038
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.
Wang P; Xu Z
BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523
[TBL] [Abstract][Full Text] [Related]
27. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
28. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.
Diaz de Leon A; Cronkhite JT; Katzenstein AL; Godwin JD; Raghu G; Glazer CS; Rosenblatt RL; Girod CE; Garrity ER; Xing C; Garcia CK
PLoS One; 2010 May; 5(5):e10680. PubMed ID: 20502709
[TBL] [Abstract][Full Text] [Related]
29. Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.
Gaysinskaya V; Stanley SE; Adam S; Armanios M
Chest; 2020 Dec; 158(6):2449-2457. PubMed ID: 32710892
[TBL] [Abstract][Full Text] [Related]
30. Adult-onset pulmonary fibrosis caused by mutations in telomerase.
Tsakiri KD; Cronkhite JT; Kuan PJ; Xing C; Raghu G; Weissler JC; Rosenblatt RL; Shay JW; Garcia CK
Proc Natl Acad Sci U S A; 2007 May; 104(18):7552-7. PubMed ID: 17460043
[TBL] [Abstract][Full Text] [Related]
31. Rare and Common Variants in
Zhang D; Povysil G; Kobeissy PH; Li Q; Wang B; Amelotte M; Jaouadi H; Newton CA; Maher TM; Molyneaux PL; Noth I; Martinez FJ; Raghu G; Todd JL; Palmer SM; Haefliger C; Platt A; Petrovski S; Garcia JA; Goldstein DB; Garcia CK
Am J Respir Crit Care Med; 2022 Jul; 206(1):56-69. PubMed ID: 35417304
[No Abstract] [Full Text] [Related]
32. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
33. [A concise review of telomere and telomerase-related genetic markers in fibrotic lung diseases].
Fan YL; Ye Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):952-956. PubMed ID: 33406566
[TBL] [Abstract][Full Text] [Related]
34. The molecular genetics of the telomere biology disorders.
Bertuch AA
RNA Biol; 2016 Aug; 13(8):696-706. PubMed ID: 26400640
[TBL] [Abstract][Full Text] [Related]
35. Telomeres in lung disease.
Gansner JM; Rosas IO
Transl Res; 2013 Dec; 162(6):343-52. PubMed ID: 23618685
[TBL] [Abstract][Full Text] [Related]
36. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.
Kropski JA; Lawson WE; Young LR; Blackwell TS
Dis Model Mech; 2013 Jan; 6(1):9-17. PubMed ID: 23268535
[TBL] [Abstract][Full Text] [Related]
37. Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.
Boyraz B; Moon DH; Segal M; Muosieyiri MZ; Aykanat A; Tai AK; Cahan P; Agarwal S
J Clin Invest; 2016 Sep; 126(9):3377-82. PubMed ID: 27482890
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years.
van der Vis JJ; van der Smagt JJ; Hennekam FAM; Grutters JC; van Moorsel CHM
Chest; 2020 Aug; 158(2):612-619. PubMed ID: 32315675
[TBL] [Abstract][Full Text] [Related]
39. The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.
Arish N; Petukhov D; Wallach-Dayan SB
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248154
[TBL] [Abstract][Full Text] [Related]
40. Telomere shortening in familial and sporadic pulmonary fibrosis.
Cronkhite JT; Xing C; Raghu G; Chin KM; Torres F; Rosenblatt RL; Garcia CK
Am J Respir Crit Care Med; 2008 Oct; 178(7):729-37. PubMed ID: 18635888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
